Showing results (101-110 of 213) with videos related to

Sort By:
Pageof 22
BMC Cancer|June 7, 2014
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinomaSara Marinelli, Veronica Salvatore, Marco Baron Toaldo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 3, 2019
Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRIDavide Ippolito, Simone Famularo, Alessandro Giani, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosisLuigi Bolondi, Fabio Piscaglia, Angelo Gatta, et al.
European Journal of Gastroenterology & Hepatology|May 26, 2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?Fabio Farinati, Adriana Sergio, Anna Giacomin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2010
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian studyEdoardo G Giannini, Vincenzo Savarino, Domenico Risso, et al.
Cancers|December 11, 2022
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with ImmunotherapyAndrea De Giglio, Elisa Tassinari, Arianna Zappi, et al.
Future Oncology (London, England)|November 1, 2014
Refining sorafenib therapy: lessons from clinical practiceLuigi Bolondi, Antonio Craxi, Franco Trevisani, et al.
Frontiers in Immunology|December 8, 2025
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicitiesSimone Rossi, Elisa Andrini, Rita Rinaldi, et al.
The American Journal of Gastroenterology|January 13, 2006
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinomaMaria Chiara Cantarini, Franco Trevisani, Antonio Maria Morselli-Labate, et al.
Pageof 22